Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation
- First Posted Date
- 2024-05-22
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- CASI Pharmaceuticals (China) Co., Ltd.
- Target Recruit Count
- 67
- Registration Number
- NCT06425276
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, China
News
No news found